{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:13:33Z","timestamp":1781824413605,"version":"3.54.5"},"reference-count":73,"publisher":"Elsevier","isbn-type":[{"value":"9780443344435","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.irn.2026.01.008","type":"book-chapter","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:14:32Z","timestamp":1770120872000},"page":"1-24","source":"Crossref","is-referenced-by-count":1,"title":["Glutamate and glutamine metabolism in neurodegenerative diseases"],"prefix":"10.1016","author":[{"given":"Kesharthini","family":"Karthikeyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowshika","family":"Velmurugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhi","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murugan","family":"Sevanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5468-2129","authenticated-orcid":false,"given":"Subashchandrabose","family":"Chinnathambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.irn.2026.01.008_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111349","article-title":"Glutamatergic dysfunction in neurodegenerative diseases focusing on Parkinson\u2019s disease: Role of glutamate modulators","author":"Almohmadi","year":"2025","journal-title":"Brain Research Bulletin"},{"issue":"3","key":"10.1016\/bs.irn.2026.01.008_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70029","article-title":"The glutamate\/GABA-glutamine cycle: Insights, updates, and advances","volume":"169","author":"Andersen","year":"2025","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2026.01.008_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108719","article-title":"Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration","volume":"196","author":"Andersen","year":"2021","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/bs.irn.2026.01.008_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115587","article-title":"Revisiting glutamate excitotoxicity in amyotrophic lateral sclerosis and age-related neurodegeneration","volume":"25","author":"Arnold","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/bs.irn.2026.01.008_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040864","article-title":"Group I mGluRs in therapy and diagnosis of Parkinson\u2019s disease: Focus on mGluR5 subtype","volume":"10","author":"Azam","year":"2022","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/bs.irn.2026.01.008_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/nu15122794","article-title":"Glutamine Supplementation preserves glutamatergic neuronal activity in the infralimbic cortex, which delays the onset of mild cognitive impairment in 3\u00d7Tg-AD female mice","volume":"15","author":"Baek","year":"2023","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/bs.irn.2026.01.008_bib7","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3390\/ph17101265","article-title":"NMDA receptors: Distribution, role, and insights into neuropsychiatric disorders","volume":"17","author":"Beaurain","year":"2024","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/bs.irn.2026.01.008_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40263-017-0408-1","article-title":"Safinamide: A review in Parkinson\u2019s disease","volume":"31","author":"Blair","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/bs.irn.2026.01.008_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106918","article-title":"Early \u03b1-synuclein aggregation decreases corticostriatal glutamate drive and synapse density","volume":"210","author":"Brzozowski","year":"2025","journal-title":"Neurobiology of Disease"},{"issue":"20","key":"10.1016\/bs.irn.2026.01.008_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207452","article-title":"The dual role of glutamatergic neurotransmission in Alzheimer\u2019s disease: From pathophysiology to pharmacotherapy","volume":"21","author":"Bukke","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"10.1016\/bs.irn.2026.01.008_bib11","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s12264-022-00985-9","article-title":"Physiological roles of \u03b2-amyloid in regulating synaptic function: Implications for AD pathophysiology","volume":"39","author":"Cai","year":"2023","journal-title":"Neuroscience Bulletin"},{"key":"10.1016\/bs.irn.2026.01.008_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105697","article-title":"Striatal glutamatergic hyperactivity in Parkinson\u2019s disease","volume":"168","author":"Campanelli","year":"2022","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.irn.2026.01.008_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/bs.apcsb.2024.07.001","article-title":"Nuclear transport protein suppresses Tau neurodegeneration","volume":"143","author":"Chinnathambi","year":"2025","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"key":"10.1016\/bs.irn.2026.01.008_bib14","first-page":"201","article-title":"The cross-talk between ApoE and Tau protein in Alzheimer\u2019s disease","volume":"146","author":"Chinnathambi","year":"2025","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"key":"10.1016\/bs.irn.2026.01.008_bib15","first-page":"179","article-title":"The aggregation propensity of Tau and amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"146","author":"Chinnathambi","year":"2025","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"key":"10.1016\/bs.irn.2026.01.008_bib16","first-page":"221","article-title":"Modifiable chemical risk factors for amyloid-\u03b2 and Tau protein in Alzheimer\u2019s disease","volume":"146","author":"Chinnathambi","year":"2025","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"key":"10.1016\/bs.irn.2026.01.008_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2025.01.005","article-title":"Internalization of extracellular Tau oligomers in Alzheimer\u2019s disease","volume":"126","author":"Chinnathambi","year":"2025","journal-title":"Advances in Clinical Chemistry"},{"issue":"6","key":"10.1016\/bs.irn.2026.01.008_bib18","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.3390\/ijms10062510","article-title":"Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders","volume":"10","author":"Choonara","year":"2009","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.01.008_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.redox.2018.01.008","article-title":"13 reasons why the brain is susceptible to oxidative stress","volume":"15","author":"Cobley","year":"2018","journal-title":"Redox Biology"},{"issue":"8","key":"10.1016\/bs.irn.2026.01.008_bib20","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/bs.irn.2026.01.008_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2020.11.038","article-title":"Glutaminase in microglia: A novel regulator of neuroinflammation","volume":"92","author":"Ding","year":"2021","journal-title":"Brain, Behavior, and Immunity"},{"issue":"15","key":"10.1016\/bs.irn.2026.01.008_bib22","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.neuron.2023.05.002","article-title":"NMDA receptor functions in health and disease: Old actor, new dimensions","volume":"111","author":"Dupuis","year":"2023","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/bs.irn.2026.01.008_bib23","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1089\/ars.2009.2444","article-title":"Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis","volume":"11","author":"Foran","year":"2009","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/bs.irn.2026.01.008_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102357","article-title":"Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance","volume":"99","author":"Gadhave","year":"2024","journal-title":"Ageing Research Reviews"},{"issue":"16","key":"10.1016\/bs.irn.2026.01.008_bib25","doi-asserted-by":"crossref","first-page":"16702","DOI":"10.1021\/acsomega.9b00692","article-title":"Molecular Cobalt(II) Complexes for Tau Polymerization in Alzheimer\u2019s Disease","volume":"4","author":"Gorantla","year":"2019","journal-title":"ACS Omega"},{"issue":"17","key":"10.1016\/bs.irn.2026.01.008_bib26","doi-asserted-by":"crossref","first-page":"11131","DOI":"10.1021\/acsomega.9b03497","article-title":"Amyloid-\u03b2-derived peptidomimetics inhibits tau aggregation","volume":"6","author":"Gorantla","year":"2021","journal-title":"ACS Omega"},{"issue":"19","key":"10.1016\/bs.irn.2026.01.008_bib27","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1093\/hmg\/ddg267","article-title":"Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice","volume":"12","author":"Guo","year":"2003","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.008_bib28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1523\/JNEUROSCI.17-01-00204.1997","article-title":"Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons","volume":"17","author":"G\u00f6tz","year":"1997","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2026.01.008_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1575453","article-title":"The roles of microglia and astrocytes in neuroinflammation of Alzheimer\u2019s disease","volume":"19","author":"Han","year":"2025","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.irn.2026.01.008_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-7321-7_1","article-title":"NMDA receptors in the central nervous system","volume":"1677","author":"Hansen","year":"2017","journal-title":"Methods in Molecular Biology (Clifton, N. J.)"},{"issue":"3","key":"10.1016\/bs.irn.2026.01.008_bib31","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.032539299","article-title":"Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)","volume":"99","author":"Howland","year":"2002","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2026.01.008_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.12779\/dnd.2016.15.2.43","article-title":"Long-term efficacy of memantine in Parkinson\u2019 disease dementia: An 18-month prospective perfusion single photon emission computed tomography preliminary study","volume":"15","author":"Jeong","year":"2016","journal-title":"Dementia and Neurocognitive Disorders"},{"issue":"9996","key":"10.1016\/bs.irn.2026.01.008_bib33","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/bs.irn.2026.01.008_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0168-0102(02)00009-3","article-title":"Complementary distribution of vesicular glutamate transporters in the central nervous system","volume":"42","author":"Kaneko","year":"2002","journal-title":"Neuroscience Research"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.008_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-023-02751-8","article-title":"TGF-\u03b21 signalling in Alzheimer\u2019s pathology and cytoskeletal reorganization: A specialized tau perspective","volume":"20","author":"Kapoor","year":"2023","journal-title":"Journal of Neuroinflammation"},{"issue":"4","key":"10.1016\/bs.irn.2026.01.008_bib36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.neurobiolaging.2006.02.010","article-title":"Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease","volume":"28","author":"Kashani","year":"2007","journal-title":"Neurobiology of Aging"},{"issue":"11","key":"10.1016\/bs.irn.2026.01.008_bib37","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.neurobiolaging.2007.04.010","article-title":"Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease","volume":"29","author":"Kashani","year":"2008","journal-title":"Neurobiology of Aging"},{"issue":"43","key":"10.1016\/bs.irn.2026.01.008_bib38","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1523\/JNEUROSCI.0823-20.2020","article-title":"VGluT2 expression in dopamine neurons contributes to postlesional striatal reinnervation","volume":"40","author":"Kouwenhoven","year":"2020","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2026.01.008_bib39","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.neuron.2014.10.021","article-title":"An unconventional glutamatergic circuit in the retina formed by vGluT3 amacrine cells","volume":"84","author":"Lee","year":"2014","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/bs.irn.2026.01.008_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12811","article-title":"Extracellular tau oligomers affect extracellular glutamate handling by astrocytes through downregulation of GLT-1 expression and impairment of NKA1A2 function","volume":"48","author":"Li Puma","year":"2022","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/bs.irn.2026.01.008_bib41","first-page":"2021","article-title":"Glutamic acid transporters: Targets for neuroprotective therapies in Parkinson\u2019s disease [Review]","volume":"15","author":"Li","year":"2021","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.irn.2026.01.008_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2019.00043","article-title":"The role of NMDA receptors in Alzheimer\u2019s disease","volume":"13","author":"Liu","year":"2019","journal-title":"Frontiers in Neuroscience"},{"issue":"22","key":"10.1016\/bs.irn.2026.01.008_bib43","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.3390\/ijms20225671","article-title":"Excitatory amino acid transporters in physiology and disorders of the central nervous system","volume":"20","author":"Malik","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.01.008_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.coph.2018.03.004","article-title":"Metabotropic glutamate receptors: Targets for neuroprotective therapies in Parkinson disease","volume":"38","author":"Masilamoni","year":"2018","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/bs.irn.2026.01.008_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1235163","article-title":"Calpain signaling: From biology to therapeutic opportunities in neurodegenerative disorders","volume":"10","author":"Metwally","year":"2023","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/bs.irn.2026.01.008_bib46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pbb.2018.12.010","article-title":"Amantadine enhances nigrostriatal and mesolimbic dopamine function in the rat brain in relation to motor and exploratory activity","volume":"179","author":"Nikolaus","year":"2019","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"2","key":"10.1016\/bs.irn.2026.01.008_bib47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/antiox12020517","article-title":"Oxidative stress and antioxidants in neurodegenerative disorders","volume":"12","author":"Olufunmilayo","year":"2023","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/bs.irn.2026.01.008_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101372","article-title":"Astrocytic transcription factor REST upregulates glutamate transporter EAAT2, protecting dopaminergic neurons from manganese-induced excitotoxicity","volume":"297","author":"Pajarillo","year":"2021","journal-title":"Journal of Biological Chemistry"},{"issue":"23","key":"10.1016\/bs.irn.2026.01.008_bib49","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.3390\/molecules29235744","article-title":"Glutamate: Molecular mechanisms and signaling pathway in Alzheimer\u2019s disease, a potential therapeutic target","volume":"29","author":"Puranik","year":"2024","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/bs.irn.2026.01.008_bib50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","article-title":"Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: A review of the literature","volume":"10","author":"Ramesh","year":"2023","journal-title":"AIMS Neuroscience"},{"issue":"3 1","key":"10.1016\/bs.irn.2026.01.008_bib51","first-page":"S175","article-title":"Subthalamic nucleus-mediated excitotoxicity in Parkinson\u2019s disease: A target for neuroprotection","volume":"44","author":"Rodriguez","year":"1998","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.008_bib52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/ijms24010107","article-title":"Pathogenesis of Alzheimer\u2019s disease","volume":"24","author":"Rostagno","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2026.01.008_bib53","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuron.2024.10.014","article-title":"NMDA receptors regulate the firing rate set point of hippocampal circuits without altering single-cell dynamics","volume":"113","author":"Ruggiero","year":"2025","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/bs.irn.2026.01.008_bib54","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JAD-2011-101005","article-title":"Region- and age-specific changes in glutamate transport in the A\u03b2PP23 mouse model for Alzheimer\u2019s disease","volume":"24","author":"Schallier","year":"2011","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"6-7","key":"10.1016\/bs.irn.2026.01.008_bib55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuint.2007.03.012","article-title":"The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention","volume":"51","author":"Sheldon","year":"2007","journal-title":"Neurochemistry International"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.008_bib56","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2011.08.027","article-title":"Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer\u2019s disease cortex","volume":"45","author":"Sokolow","year":"2012","journal-title":"Neurobiology of Disease"},{"issue":"11","key":"10.1016\/bs.irn.2026.01.008_bib57","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"\u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.irn.2026.01.008_bib58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neubiorev.2021.11.044","article-title":"Subthalamic burst firing: A pathophysiological target in Parkinson\u2019s disease","volume":"132","author":"Tai","year":"2022","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"10.1016\/bs.irn.2026.01.008_bib59","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neures.2022.03.001","article-title":"Amyloid-\u03b2 oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer\u2019s disease","volume":"180","author":"Taniguchi","year":"2022","journal-title":"Neuroscience Research"},{"issue":"24","key":"10.1016\/bs.irn.2026.01.008_bib60","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.3390\/ijms21249607","article-title":"The regulation of astrocytic glutamate transporters in health and neurodegenerative diseases","volume":"21","author":"Todd","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.008_bib61","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1074\/jbc.M003779200","article-title":"Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity","volume":"276","author":"Trotti","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.irn.2026.01.008_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/NDT.S4048","article-title":"Update on the use of memantine in Alzheimer\u2019s disease","volume":"5","author":"van Marum","year":"2009","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"2","key":"10.1016\/bs.irn.2026.01.008_bib63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jnc.14970","article-title":"Regulation of NMDA glutamate receptor functions by the GluN2 subunits","volume":"154","author":"Vieira","year":"2020","journal-title":"Journal of Neurochemistry"},{"issue":"7-8","key":"10.1016\/bs.irn.2026.01.008_bib64","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neuint.2006.10.007","article-title":"Glutamate-glutamine cycling in Alzheimer\u2019s disease","volume":"50","author":"Walton","year":"2007","journal-title":"Neurochemistry International"},{"key":"10.1016\/bs.irn.2026.01.008_bib65","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fnins.2020.585584","article-title":"Molecular mechanisms of glutamate toxicity in Parkinson\u2019s disease [Review]","volume":"14","author":"Wang","year":"2020","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.irn.2026.01.008_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.952096","article-title":"EAAT2 as a therapeutic research target in Alzheimer\u2019s disease: A systematic review","volume":"16","author":"Wood","year":"2022","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.irn.2026.01.008_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1375843","article-title":"GluN2B-containing NMDA receptor attenuated neuronal apoptosis in the mouse model of HIBD through inhibiting endoplasmic reticulum stress-activated PERK\/eIF2\u03b1 signaling pathway","volume":"17","author":"Wu","year":"2024","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/bs.irn.2026.01.008_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-025-01576-w","article-title":"Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases\u2014an update","author":"Wu","year":"2025","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/bs.irn.2026.01.008_bib69","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fncel.2021.702824","article-title":"EAAT2 expression in the hippocampus, subiculum, entorhinal cortex and superior temporal gyrus in alzheimer\u2019s disease [Original Research]","volume":"15","author":"Yeung","year":"2021","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.01.008_bib70","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-023-00636-1","article-title":"Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer\u2019s disease","volume":"18","author":"Yu","year":"2023","journal-title":"Molecular Neurodegeneration"},{"issue":"6","key":"10.1016\/bs.irn.2026.01.008_bib71","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.drudis.2020.04.001","article-title":"Regulation of microglia by glutamate and its signal pathway in neurodegenerative diseases","volume":"25","author":"Zhang","year":"2020","journal-title":"Drug Discovery Today"},{"key":"10.1016\/bs.irn.2026.01.008_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1118078","article-title":"A mini-review of the role of vesicular glutamate transporters in Parkinson\u2019s disease","volume":"16","author":"Zhao","year":"2023","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/bs.irn.2026.01.008_bib73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1427.023","article-title":"Oxidative stress in Parkinson\u2019s disease: A mechanism of pathogenic and therapeutic significance","volume":"1147","author":"Zhou","year":"2008","journal-title":"Annals of the New York Academy of Sciences"}],"container-title":["International Review of Neurobiology","Brain Energy Metabolism in Alzheimers Disease - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:00:24Z","timestamp":1781208024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774226000085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443344435"],"references-count":73,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2026.01.008","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}